DL-alpha-Tocopherol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
DL-alpha-Tocopherol
Accession Number
DB14476
Description
Not Available
Type
Small Molecule
Groups
Approved, Experimental, Investigational
Structure
Thumb
Weight
Average: 430.717
Monoisotopic: 430.38108085
Chemical Formula
C29H50O2
Synonyms
  • (+)-alpha-tocopherol
  • (±)-α-tocopherol
  • all-rac-alpha-tocopherol
  • DL-5,7,8-trimethyltocol
  • DL-alpha tocopherol
  • DL-α-tocopherol
  • Vitamin E DL-alpha
External IDs
  • E-307C
  • Ins no.307C
  • INS-307C

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
OrlistatOrlistat can cause a decrease in the absorption of DL-alpha-Tocopherol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
No interactions found.

Products

Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Advanced E With Non-medicinal Grape Seed ExtractCapsuleOralVita Health Products Inc2000-03-012002-07-30Canada
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Antiphlamine Coin PlasterDL-alpha-Tocopherol (0.308 mg/0.2832g) + Diphenhydramine (0.246 mg/0.2832g) + Levomenthol (2.769 mg/0.2832g) + Methyl salicylate (5.541 mg/0.2832g) + Nonivamide (0.046 mg/0.2832g) + Peppermint oil (0.693 mg/0.2832g) + Synthetic camphor (1.108 mg/0.2832g)PatchTopicalHanul Trading Co., Ltd.2016-10-10Not applicableUs
Eden With Vitamins A, C, and EDL-alpha-Tocopherol (1.8 unit) + Ascorbic acid (10 mg) + Beta carotene (0.8 mg)TabletOralWarner Lambert Canada Inc.Not applicableNot applicableCanada
P.N. Vitamin-mineral DrinkDL-alpha-Tocopherol (30 unit) + Ascorbic acid (60 mg) + Beta carotene (5550 unit) + Biotin (300 mcg) + Cyanocobalamin (6 mcg) + Folic acid (0.4 mg) + Iron (6 mg) + Nicotinamide (20 mg) + Calcium pantothenate (10 mg) + Pyridoxine hydrochloride (2 mg) + Riboflavin (1.7 mg) + Thiamine (1.5 mg) + Vitamin A palmitate (3150 unit) + Vitamin D (400 unit)LiquidOralChanges InternationalNot applicableNot applicableCanada
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Antiphlamine Coin PlasterDL-alpha-Tocopherol (0.308 mg/0.2832g) + Diphenhydramine (0.246 mg/0.2832g) + Levomenthol (2.769 mg/0.2832g) + Methyl salicylate (5.541 mg/0.2832g) + Nonivamide (0.046 mg/0.2832g) + Peppermint oil (0.693 mg/0.2832g) + Synthetic camphor (1.108 mg/0.2832g)PatchTopicalHanul Trading Co., Ltd.2016-10-10Not applicableUs
CitraNatal HarmonyDL-alpha-Tocopherol (30 [iU]/1) + Calcium citrate tetrahydrate (100 mg/1) + Cholecalciferol (400 [iU]/1) + Doconexent (250 mg/1) + Docusate sodium (50 mg/1) + Folic acid (1 mg/1) + Iron (28 mg/1) + Pyridoxine hydrochloride (25 mg/1)Capsule, gelatin coatedOralMission Pharmacal2011-04-18Not applicableUs
CitraNatal HarmonyDL-alpha-Tocopherol (30 [iU]/1) + Calcium citrate tetrahydrate (104 mg/1) + Cholecalciferol (400 [iU]/1) + Doconexent (260 mg/1) + Docusate sodium (50 mg/1) + Folic acid (1 mg/1) + Iron (30 mg/1) + Pyridoxine hydrochloride (25 mg/1)Capsule, gelatin coatedOralMission Pharmacal2012-01-15Not applicableUs
CitraNatal HarmonyDL-alpha-Tocopherol (30 [iU]/1) + Calcium citrate tetrahydrate (100 mg/1) + Cholecalciferol (400 [iU]/1) + Doconexent (250 mg/1) + Docusate sodium (50 mg/1) + Folic acid (1 mg/1) + Iron (27 mg/1) + Pyridoxine hydrochloride (25 mg/1)Capsule, gelatin coatedOralMission Pharmacal2010-04-27Not applicableUs
Escavite DDL-alpha-Tocopherol (30 [iU]/1) + Ascorbic acid (100 mg/1) + Beta carotene (2500 [iU]/1) + Biotin (45 ug/1) + Cholecalciferol (600 [iU]/1) + Cupric oxide (2 mg/1) + Ferrous cysteine glycinate (6 mg/1) + Folic acid (400 ug/1) + Hydroxocobalamin (6 ug/1) + Magnesium oxide (60 mg/1) + Niacin (20 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxine hydrochloride (2 mg/1) + Riboflavin (1.7 mg/1) + Sodium fluoride (0.25 mg/1) + Thiamine hydrochloride (1.5 mg/1) + Zinc oxide (15 mg/1)Tablet, chewableOralGM Pharmaceuticals, INC2014-03-032018-11-01Us
Prenate DHADL-alpha-Tocopherol (40 [iU]/1) + Ascorbic acid (90 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (25 ug/1) + Doconexent (300 mg/1) + Ferrous asparto glycinate (18 mg/1) + Folic acid (1 mg/1) + Calcium formate (155 mg/1) + Magnesium oxide (50 mg/1) + Pyridoxine hydrochloride (26 mg/1)Capsule, gelatin coatedOralAvion Pharmaceuticals, Llc2014-06-05Not applicableUs
Prenate DHADL-alpha-Tocopherol (10 [iU]/1) + Ascorbic acid (90 mg/1) + Calcium carbonate (145 mg/1) + Cholecalciferol (220 [iU]/1) + Cyanocobalamin (13 ug/1) + Doconexent (300 mg/1) + Ferrous fumarate (28 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (50 mg/1) + Pyridoxine hydrochloride (26 mg/1)Capsule, gelatin coatedOralAvion Pharmaceuticals, Llc2012-01-312016-04-30Us
Prenate EssentialDL-alpha-Tocopherol (10 [iU]/1) + Ascorbic acid (90 mg/1) + Biotin (280 ug/1) + Calcium carbonate (145 mg/1) + Cholecalciferol (220 [iU]/1) + Cyanocobalamin (13 ug/1) + Doconexent (300 mg/1) + Ferrous fumarate (29 mg/1) + Folic acid (1 mg/1) + Icosapent (40 mg/1) + Magnesium oxide (50 mg/1) + Potassium Iodide (150 ug/1) + Pyridoxine hydrochloride (26 mg/1)Tablet, coatedOralAvion Pharmaceuticals, Llc2012-01-312015-09-30Us
Prenate MiniDL-alpha-Tocopherol (10 [iU]/1) + Ascorbic acid (60 mg/1) + Biotin (280 ug/1) + Calcium carbonate (100 mg/1) + Cholecalciferol (220 [iU]/1) + Cyanocobalamin (13 ug/1) + Doconexent (350 mg/1) + Folic acid (1 mg/1) + Iron (29 mg/1) + Lowbush blueberry (25 mg/1) + Magnesium oxide (25 mg/1) + Potassium Iodide (150 ug/1) + Pyridoxine hydrochloride (26 mg/1)Capsule, gelatin coatedOralAvion Pharmaceuticals, Llc2012-05-152016-09-30Us
Quflora PediatricDL-alpha-Tocopherol (15 [iU]/1) + Ascorbic acid (60 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric sulfate pentahydrate (1 mg/1) + Cyanocobalamin (4 ug/1) + Folic acid (100 ug/1) + Levomefolic acid (108 ug/1) + Magnesium oxide (15 mg/1) + Nicotinamide (5 mg/1) + Pyridoxine hydrochloride (1.5 mg/1) + Riboflavin (1.3 mg/1) + Sodium fluoride (1 mg/1) + Thiamine hydrochloride (1.2 mg/1) + Vitamin A acetate (1200 [iU]/1)Tablet, chewableOralCarwin Associates, Inc2014-01-06Not applicableUs

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as tocopherols. These are vitamin E derivatives containing a saturated trimethyltridecyl chain attached to the carbon C6 atom of a benzopyran ring system. The differ from tocotrienols that contain an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain.
Kingdom
Organic compounds
Super Class
Lipids and lipid-like molecules
Class
Prenol lipids
Sub Class
Quinone and hydroquinone lipids
Direct Parent
Tocopherols
Alternative Parents
Diterpenoids / 1-benzopyrans / Alkyl aryl ethers / Benzenoids / Oxacyclic compounds / Hydrocarbon derivatives
Substituents
1-benzopyran / Alkyl aryl ether / Aromatic heteropolycyclic compound / Benzenoid / Benzopyran / Chromane / Diterpenoid / Ether / Hydrocarbon derivative / Organic oxygen compound
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
vitamin E (ALPHA-TOCOPHEROL)

Chemical Identifiers

UNII
7QWA1RIO01
CAS number
10191-41-0
InChI Key
GVJHHUAWPYXKBD-UHFFFAOYSA-N
InChI
InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3
IUPAC Name
2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-ol
SMILES
CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1

References

General References
Not Available
ChemSpider
2032
BindingDB
50436220
RxNav
220893
ChEBI
93909
ChEMBL
CHEMBL49563
AHFS Codes
  • 88:20.00 — Vitamin E

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedTreatmentAlzheimer's Disease (AD)1
2, 3CompletedPreventionAtherosclerosis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CapsuleOral
PatchTopical
Capsule, gelatin coatedOral
TabletOral
CapsuleOral
LiquidOral
Tablet, coatedOral
Tablet, chewableOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility7.04e-06 mg/mLALOGPS
logP8.84ALOGPS
logP10.51ChemAxon
logS-7.8ALOGPS
pKa (Strongest Acidic)10.8ChemAxon
pKa (Strongest Basic)-4.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area29.46 Å2ChemAxon
Rotatable Bond Count12ChemAxon
Refractivity135.37 m3·mol-1ChemAxon
Polarizability56.18 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-0742900000-e04f7b35db8df7846abb
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-1910000000-cc361786eb3f51f45d19
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-066r-3930000000-979a3e4c33d64d0c6215
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-0110900000-d5b620320c97f00ad562
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-01t9-0730900000-36e33000e46f480ceb9d
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-03e9-0921200000-7c36ba360f71f0d4b512

Drug created on July 06, 2018 12:47 / Updated on August 12, 2020 21:57

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates